What is the recommended adult dose of polymyxin B (Polymyxin B) and sulfamethoxazole (Sulfamethoxazole)/trimethoprim (Trimethoprim) eye drops for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adult Dosing for Polymyxin B Sulfate/Trimethoprim Eye Drops for Bacterial Conjunctivitis

The recommended adult dose is one drop in the affected eye(s) every 3 hours (maximum 6 doses per day) for 7-10 days. 1

Standard Dosing Regimen

  • Instill 1 drop every 3 hours while awake (approximately 6 times daily) in the affected eye(s) 1
  • Treatment duration: 7-10 days for mild to moderate bacterial conjunctivitis 1
  • This dosing schedule applies equally to adults and children over 2 months of age 1

Important Clinical Context

While polymyxin B/trimethoprim is FDA-approved and effective for bacterial conjunctivitis, newer fluoroquinolones (moxifloxacin, azithromycin, gatifloxacin) are now preferred as first-line agents due to superior efficacy and faster symptom resolution 2

Comparative Efficacy Considerations

  • Moxifloxacin achieves significantly faster cure rates than polymyxin B/trimethoprim: 81% complete resolution at 48 hours versus 44% (P=0.001) 3
  • Moxifloxacin requires only 3 times daily dosing versus 6 times daily for polymyxin B/trimethoprim, improving compliance 3
  • Fluoroquinolones achieve better tissue penetration and broader coverage for bacterial conjunctivitis 2

When Polymyxin B/Trimethoprim Remains Appropriate

  • Cost-effective alternative when fluoroquinolones are not accessible or affordable 2
  • Effective for common pathogens: Haemophilus influenzae and Streptococcus pneumoniae with cure/improvement rates of 92-93% by end of therapy 4
  • Well-tolerated with minimal adverse effects reported in pediatric and adult populations 5

Clinical Monitoring

  • Expect improvement within 24-48 hours: reduced discharge, pain, and lid edema 2
  • If no improvement by 48 hours, consider switching to a fluoroquinolone or obtaining cultures 2
  • Complete the full 7-10 day course even if symptoms resolve earlier to prevent resistance 1

Important Contraindications

Do not use polymyxin B/trimethoprim for:

  • Severe bacterial keratitis (requires fluoroquinolones with loading doses) 2
  • Contact lens-related infections 2
  • Gonococcal or chlamydial conjunctivitis (requires systemic antibiotics) 2
  • Lesions close to the limbus 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.